References:
1. BDA criticises misreporting of WHO guidance. Br Dent J229, 215 (2020). https://doi.org/10.1038/s41415-020-2088-3
2.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
3. Rossi, G.A., Sacco, O., Mancino, E. et al. Differences and
similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding
domain recognition and host cell infection with support of cellular
serine proteases. Infection (2020).
https://doi.org/10.1007/s15010-020-01486-5
4. Sungnak, W., Huang, N., Bécavin, C. et al. SARS-CoV-2 entry
factors are highly expressed in nasal epithelial cells together with
innate immune genes. Nat Med 26, 681–687 (2020).
https://doi.org/10.1038/s41591-020-0868-6
5. Renhong Yan et al., Structural basis for the recognition of
SARS-CoV-2 by full-length human ACE2, Science 27 Mar 2020: Vol. 367,
Issue 6485, pp. 1444-1448 DOI: 10.1126/science.abb2762
6. World Health Organization. Infection prevention and control during
health care when coronavirus disease (COVID-19) is suspected or
confirmed.
https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4.
Published 2020. Accessed 23 July, 2020
7. World Health Organization. Publication/Guidelines. Natural
Ventilation for Infection Control in Health-Care Settings.
https://apps.who.int/iris/bitstream/handle/10665/44167/9789241547857_eng.pdf.
Published 2009. Accessed 23 July, 2020.